In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on CVS Caremark CVS, but removed the $80.00 price target.
In the report, Morgan Stanley noted, “We are hosting CVS's CFO Dave Denton on Thursday 5/29 at 1pm as part of our CEO/CFO conference call series. On the call we will discuss key investor debates, highlighted below.”
CVS Caremark closed on Tuesday at $77.17.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in